Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Biomarkers ; 14(7): 486-92, 2009 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19863187

RESUMO

Serum gamma-glutamyltransferase (GGT) is thought to derive from the liver, but its values predict morbidity and mortality for several diseases, such as cardiac infarction, stroke, diabetes, renal failure and cancer. We assessed total GGT and its fractions in the culture supernatants of human cell lines (melanoma, prostate cancer, bronchial epithelium) by gel filtration chromatography. We also compared the GGT elution profile in plasma and the corresponding very-low-density lipoprotein (VLDL) fraction. All the cell lines tested released soluble GGT whose activity increased in parallel with the cell growth. Released GGT presented a molecular weight of 2000 kDa, identical to the b-GGT fraction of human plasma and corresponding to that of VLDL. But ultracentrifugation studies showed that b-GGT had a higher density than VLDL. The b-GGT present in human plasma can be produced by tissues other than the liver, thus explaining the increase of serum GGT observed in diseases of other organs.


Assuntos
gama-Glutamiltransferase/sangue , gama-Glutamiltransferase/metabolismo , Biomarcadores/sangue , Biomarcadores/metabolismo , Western Blotting , Linhagem Celular , Linhagem Celular Tumoral , Cromatografia em Gel , Humanos , Lipoproteínas VLDL/sangue , Fígado/enzimologia , Peso Molecular , Solubilidade , Ultracentrifugação , gama-Glutamiltransferase/química
2.
Clin Biochem ; 43(15): 1246-8, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20691173

RESUMO

OBJECTIVES: Elevation of serum gamma-glutamyltransferase (GGT), in absence of a clinically significant liver damage, is often found in Myotonic Dystrophy type-1 (DM1). In this study we investigated if a specific GGT fraction pattern is present in DM1. DESIGNS AND METHODS: We compared total and fractional GGT values (b-, m-, s-, f-GGT) among patients with DM1 or liver disease (LD) and healthy subjects (HS). RESULTS: The increase of GGT in DM1 and LD, vs HS, was mainly due to s-GGT (median: 32.7; 66.7; and 7.9 U/L, respectively), and b-GGT (8.5; 18.9; and 2.1 U/L). The subset of DM1 patients matched with HS with corresponding serum GGT showed higher b-GGT (6.0 vs 4.2 U/L). CONCLUSIONS: DM1 patients with normal total GGT values showed an alteration of the production and release in the blood of GGT fractions. Since increased s-GGT is also found in LD, a sub-clinical liver damage likely occurs in DM1 subjects apparently free of liver disease.


Assuntos
Saúde , Hepatopatias/sangue , Hepatopatias/enzimologia , Distrofia Miotônica/sangue , Distrofia Miotônica/enzimologia , gama-Glutamiltransferase/sangue , Adulto , Estudos de Casos e Controles , Fracionamento Químico , Feminino , Humanos , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA